Overview A Study to Assess the Pharmacokinetics and Food Effect of SR419 in Healthy Subjects Status: Completed Trial end date: 2021-03-12 Target enrollment: Participant gender: Summary This will be an open-label, single-site, Phase I study to evaluate the PK, safety, and tolerability of SR419 in healthy volunteers. Phase: Phase 1 Details Lead Sponsor: SIMR (Australia) Biotech Pty LtdSIMR (Australia) Biotech Pty Ltd.